再鼎医药涨近4%一季度总收入同比增长22%至1.06亿美元

动脉网
09 May

再鼎医药(09688)股价涨近4%,截至发稿报23.2港元,成交额达6519.23万港元。公司发布截至2025年3月31日的未经审计业绩,总收入为1.06亿美元,同比增长22.19%;研发开支为6072.9万美元,同比增长11.13%。2025年第一季度产品收入净额为1.057亿美元,同比增长21%,按固定汇率计算增长23%。这一增长主要由卫伟迦、则乐和纽再乐的销售额增加驱动。公司总裁兼首席运营官...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10